Andrew Flanagan is CEO of Telcare and a member of its Board of Directors. As CEO, Andrew is responsible for setting Telcare's strategic direction and driving growth in its portfolio of healthcare offerings, including the first FDA-cleared cellular blood glucose monitor. Telcare provides technology solutions that enable key healthcare stakeholders to better manage chronic conditions and achieve improved clinical outcomes that cost less. Andrew has focused his career in the technology and healthcare industries and is recognized for his innovative leadership. With more than 25 years of business transformation and sales expertise, Andrew has held leadership roles at Siemens Healthcare, SAP and emerging growth companies. As CEO of ESM Solutions, Andrew led the company from incubation through expansion to a successful private exit.